| P2093 | author name string | Robert H Paul | |
| | Eileen M Martin-Thormeyer | |
| P2860 | cites work | Detection and Analysis of Hepatitis C Virus Sequences in Cerebrospinal Fluid | Q27472903 |
| | Hepatitis C Virus Neuroinvasion: Identification of Infected Cells | Q27487561 |
| | Clinicopathologic correlates of hepatitis C virus in brain: A pilot study | Q27489380 |
| | Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection | Q27491050 |
| | Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms | Q28372016 |
| | The neural basis of addiction: a pathology of motivation and choice | Q29615901 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex | Q29619998 |
| | The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 |
| | Molecular basis for interactions of HIV and drugs of abuse. | Q30332159 |
| | Assessing psychopathic attributes in a noninstitutionalized population | Q30419306 |
| | Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. | Q30694974 |
| | Alcoholism and AIDS: magnetic resonance imaging approaches for detecting interactive neuropathology | Q30712330 |
| | Neuroimaging in human immunodeficiency virus infection | Q30977755 |
| | A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. | Q31013545 |
| | Structural and metabolic brain changes in the striatum associated with methamphetamine abuse | Q31112200 |
| | Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers | Q31874181 |
| | Neuropsychological aspects of coinfection with HIV and hepatitis C virus | Q33888133 |
| | Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse | Q33917628 |
| | Neurocognition in individuals co-infected with HIV and hepatitis C. | Q33917713 |
| | Relationship between alcohol use/abuse, HIV infection and neuropsychological performance in African American men | Q33938397 |
| | Proinflammatory synergism of ethanol and HIV-1 Tat protein in brain tissue | Q33983670 |
| | HIV dementia: the role of the basal ganglia and dopaminergic systems | Q34098768 |
| | Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study | Q34220050 |
| | Neuropsychiatric impact of hepatitis C on advanced HIV | Q34313868 |
| | Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy | Q48748890 |
| | Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. | Q49079166 |
| | Posttraumatic stress disorder and drug disorders: testing causal pathways. | Q50861285 |
| | Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study. | Q50900268 |
| | Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. | Q51903857 |
| | Opiate addicts lack error-dependent activation of rostral anterior cingulate. | Q51942384 |
| | Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? | Q51991799 |
| | Delayed nonmatch-to-sample performance in HIV-seropositive and HIV-seronegative polydrug abusers. | Q52007292 |
| | Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users. | Q52061222 |
| | Verbal working memory in HIV-seropositive drug users. | Q52166222 |
| | Drug abusers show impaired performance in a laboratory test of decision making. | Q52167916 |
| | Psychometric characteristics of the Wender Utah Rating Scale (WURS): reliability and factor structure for men and women. | Q52212273 |
| | A population-based study of cigarette smoking among illicit drug users in the United States. | Q52281287 |
| | Effects of chronic alcohol abuse and HIV infection on brain phosphorus metabolites | Q71776894 |
| | Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia | Q72340585 |
| | Working memory deficits in HIV-seropositive drug users | Q73760195 |
| | HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study | Q80488881 |
| | Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy | Q82177447 |
| | Pharmacokinetic drug interactions between drugs of abuse and antiretroviral medications: implications and management for clinical practice | Q87070383 |
| | Acceleration of HIV dementia with methamphetamine and cocaine | Q43717548 |
| | The AIDS dementia complex: I. Clinical features | Q43769670 |
| | Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Relationship to head injury | Q43838509 |
| | Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease | Q43875860 |
| | Impaired inhibitory control of behavior in chronic cocaine users | Q44026073 |
| | Cognitive impairment in methadone maintenance patients | Q44026538 |
| | Acute effects of oral cocaine on inhibitory control of behavior in humans | Q44049010 |
| | Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure | Q44071037 |
| | Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain | Q44264453 |
| | The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications | Q44332668 |
| | Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence | Q44425246 |
| | Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. | Q44566036 |
| | Patterns of selective neuronal damage in methamphetamine-user AIDS patients | Q44681453 |
| | Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons | Q44747866 |
| | Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users | Q44747873 |
| | The neural correlates of cue-induced craving in cocaine-dependent women | Q44750273 |
| | The effect of previous alcohol abuse on cognitive function in HIV infection | Q44750280 |
| | White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study | Q44761063 |
| | Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q44832144 |
| | Marijuana use and cognitive function in HIV-infected people | Q45065705 |
| | Differential effect of HIV infection and alcoholism on conflict processing, attentional allocation, and perceptual load: evidence from a Stroop Match-to-Sample task | Q45192854 |
| | Magnetic resonance imaging of white matter lesions in HIV infection | Q45235780 |
| | Morphine potentiates HIV-1 gp120-induced neuronal apoptosis | Q45270641 |
| | Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum | Q45421802 |
| | Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. | Q45423059 |
| | The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects | Q45423061 |
| | Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals | Q45423075 |
| | Stroop performance in drug users classified by HIV and hepatitis C virus serostatus | Q45667911 |
| | Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center | Q45778294 |
| | A neostriatal habit learning system in humans. | Q45979314 |
| | Effects of methamphetamine dependence and HIV infection on cerebral morphology | Q46162061 |
| | Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users | Q46230523 |
| | Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity | Q46422360 |
| | Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine | Q46455434 |
| | Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine | Q46455439 |
| | Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis | Q46470590 |
| | The effect of recent stimulant use on sustained attention in HIV-infected adults | Q46501099 |
| | The influence of executive functions, sensation seeking, and HIV serostatus on the risky sexual practices of substance-dependent individuals | Q46552386 |
| | Executive functions and risky decision-making in patients with opiate dependence | Q46591246 |
| | Psychomotor slowing in hepatitis C and HIV infection | Q47266862 |
| | Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami | Q47593228 |
| | Effects of past noninjection drug abuse upon executive function and working memory in HIV infection | Q47619363 |
| | Heroin impairs map-picture-following and memory tasks dependent on gender and orientation of the tasks | Q48090743 |
| | HIV-1 gp120 as well as alcohol affect blood-brain barrier permeability and stress fiber formation: involvement of reactive oxygen species | Q48317739 |
| | HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement | Q48343313 |
| | Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity: synergistic white matter damage | Q48426154 |
| | The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease | Q48426597 |
| | HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia | Q48447211 |
| | Contribution of alcoholism to brain dysmorphology in HIV infection: effects on the ventricles and corpus callosum | Q48459306 |
| | Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort | Q48604431 |
| | Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q34338064 |
| | The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. | Q34345975 |
| | Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. | Q34402559 |
| | Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients | Q34413083 |
| | Deficits in complex motor functions, despite no evidence of procedural learning deficits, among HIV+ individuals with history of substance dependence | Q34600046 |
| | Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise | Q34685550 |
| | Declarative and procedural memory functioning in abstinent cocaine abusers | Q34756423 |
| | Microglia in human immunodeficiency virus-associated neurodegeneration. | Q34963796 |
| | Variable patterns of neuropsychological performance in HIV-1 infection | Q34975096 |
| | Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. | Q35009483 |
| | Changing patterns in the neuropathogenesis of HIV during the HAART era. | Q35126422 |
| | Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. | Q35203216 |
| | Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management | Q35685244 |
| | Updated research nosology for HIV-associated neurocognitive disorders | Q35755761 |
| | The nervous system and hepatitis C virus | Q36054712 |
| | The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. | Q36249104 |
| | Extrahepatic immunological complications of hepatitis C virus infection. | Q36298196 |
| | Investigating neurocognitive features of hepatitis C virus infection in drug users: potential challenges and lessons learned from the HIV literature | Q36304407 |
| | Coinfection with HIV and hepatitis C virus in injection drug users and minority populations | Q36304424 |
| | Sex differences in drug abuse | Q36448618 |
| | Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice | Q36465406 |
| | HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology | Q36476904 |
| | New data from the Addiction Severity Index. Reliability and validity in three centers | Q36496246 |
| | Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance | Q36647749 |
| | Methamphetamine enhances HIV infection of macrophages | Q36691102 |
| | Chronic cigarette smoking and heavy drinking in human immunodeficiency virus: consequences for neurocognition and brain morphology | Q36744404 |
| | Cognitive dysfunction in chronic hepatitis C: a review | Q36912200 |
| | Sex-gender differences in drug abuse: a shift in the burden of proof? | Q36965992 |
| | Combined and independent effects of chronic marijuana use and HIV on brain metabolites | Q36983868 |
| | Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities | Q36983878 |
| | Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs | Q37015365 |
| | Impact of opiate-HIV-1 interactions on neurotoxic signaling | Q37015405 |
| | Evolution of HIV dementia with HIV infection | Q37073653 |
| | Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse | Q37314434 |
| | Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages | Q39161608 |
| | HIV-1, cocaine, and neuropsychological performance in African American men. | Q39537687 |
| | Hepatitis C and progression of HIV disease | Q39607141 |
| | Post-traumatic stress disorder: evidence for diagnostic validity and methods of psychological assessment | Q39769288 |
| | Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia | Q40032000 |
| | Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research | Q40161141 |
| | Characteristics of prospective memory deficits in HIV-seropositive substance-dependent individuals: preliminary observations | Q40204231 |
| | Impaired decision-making in psychopathic heroin addicts | Q40294554 |
| | Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial | Q40379555 |
| | Cognitive impulsivity and HIV serostatus in substance dependent males | Q40433717 |
| | The impact of HIV-associated neuropsychological impairment on everyday functioning | Q40509922 |
| | Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls | Q40521652 |
| | Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. | Q40547978 |
| | Neuropsychological impairment in patients with chronic hepatitis C. | Q40662481 |
| | Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. | Q40815101 |
| | Postural reflexes in patients with HIV-1 infection | Q40832033 |
| | The psychobiological model for impulsive unsocialized sensation seeking: a comparative approach | Q41209058 |
| | The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group | Q41715833 |
| | HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects | Q41902050 |
| | Variable progression of HIV-associated dementia | Q42456961 |
| | Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex | Q42467108 |
| | Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection | Q42490835 |
| | Are all drug addicts impulsive? Effects of antisociality and extent of multidrug use on cognitive and motor impulsivity | Q42787007 |
| | Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients | Q42994383 |
| | Differential display analysis of gene expression in brains from hepatitis C-infected patients. | Q42996175 |
| | Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients. | Q42996178 |
| | The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease | Q42996185 |
| | The impact of chronic hepatitis C on health-related quality of life in homeless and marginally housed individuals with HIV. | Q43032159 |
| | Differential influence of different hepatitis viruses on quality of life in HIV positive patients. | Q43033552 |
| | Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. | Q43038781 |
| | Auditory working memory in HIV-1 infection. | Q43495290 |
| | Component cognitive and motor processes of the digit symbol test: differential deficits in alcoholism, HIV infection, and their comorbidity | Q43506942 |
| | Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls | Q43606977 |
| | Evidence for a cerebral effect of the hepatitis C virus | Q43674951 |
| | Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study | Q43713570 |
| P433 | issue | 2 | |
| P921 | main subject | hepatitis C | Q154869 |
| | neuroimaging | Q551875 |
| | substance abuse | Q3184856 |
| P304 | page(s) | 215-231 | |
| P577 | publication date | 2009-05-27 | |
| P1433 | published in | Neuropsychology Review | Q7002594 |
| P1476 | title | Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features | |
| P478 | volume | 19 | |